Bartlett & Co. LLC Aridis Pharmaceuticals, Inc. Transaction History

Bartlett & Co. LLC

  • $6.16 Billion
  • Q4 2023

A detailed history of Bartlett & Co. LLC transactions in Aridis Pharmaceuticals, Inc. stock. As of the latest transaction made, Bartlett & Co. LLC holds 150 shares of ARDS stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024
BUY
$0.06 - $0.1 $9 - $15
150 New
150 $0

Others Institutions Holding ARDS

# of Institutions
2
Shares Held
50.2K
Call Options Held
0
Put Options Held
0
View Full List

About Aridis Pharmaceuticals, Inc.

ARDS Quotes by TradingView
  • Ticker ARDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,701,600
  • Description
  • Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...
More about ARDS
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email